Education
About Us
Working with TipRanks
Follow Us
Stryker Corporation (SYK)
NYSE:SYK
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
3.07Last Year’s EPS
2.81Same Quarter Last Year
Strong Buy
Based on 20 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: 4.87%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong sales growth and successful M&A activities, with positive contributions from new product launches and international markets. However, challenges such as tariffs and supply chain disruptions present hurdles. Despite these issues, the overall sentiment remains positive due to robust performance and optimistic guidance.Company Guidance
During the first quarter of 2025, Stryker demonstrated robust financial performance, achieving an impressive 10.1% organic sales growth, despite facing challenges like one fewer selling day. The MedSurg & Neurotechnology segment saw double-digit growth, while orthopedics posted high single-digit growth. Notably, the U.S. market led with strong double-digit organic growth, particularly in trauma, extremities, neurocranial, medical, endoscopy, and instruments businesses, whereas international markets, notably Australia, New Zealand, Japan, and Europe, also experienced healthy growth. The company's quarterly adjusted EPS grew by 13.6%, reaching $2.84, driven by strong sales and margin expansion. Following the first quarter's momentum, Stryker raised its full-year guidance, anticipating organic sales growth between 8.5% and 9.5% and adjusted EPS in the range of $13.20 to $13.45. The company's strategic priorities included the successful integration of Inari Medical, completed in February, and the sale of its U.S. Spinal Implants business. Additionally, Stryker aims to expand its operating margin by approximately 100 basis points, despite challenges such as tariffs, dilution from the Inari acquisition, and the loss from spinal implant contributions. The company also highlighted the ongoing strength in procedural demand, with capital products demand remaining robust, bolstered by strong Mako installations and utilization rates.Robust Organic Sales Growth
Stryker delivered a robust organic sales growth of 10.1% in the first quarter, with double-digit growth in MedSurg & Neurotechnology and high-single-digit growth in orthopedics.
Strong U.S. Performance
There was a strong U.S. performance with double-digit organic growth in trauma and extremities, neurocranial, medical, endoscopy, and instruments businesses.
International Market Growth
International sales saw healthy growth, particularly in Australia, New Zealand, Japan, and Europe, positioning international markets as significant catalysts for future growth.
EPS Growth
Stryker delivered quarterly adjusted EPS of $2.84, reflecting a 13.6% growth compared to the first quarter of 2024.
Successful M&A Activity
The acquisition of Inari Medical was completed, with integration going well. The sale of the U.S. Spinal Implants business was also completed.
Positive Revenue Guidance
Full-year organic sales growth is anticipated at 8.5% to 9.5% with adjusted EPS guidance of $13.20 to $13.45.
Recognition for Workplace Culture
Stryker was recognized for the 15th consecutive year on Great Place to Work's 100 best companies to work for list.
Strong Demand for Robotic-Assisted Surgery
Mako had its best-ever Q1 for installations in the U.S. and worldwide, with high utilization rates driving growth in hips and knees businesses.
---
SYK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SYK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 01, 2025 | $373.99 | $378.22 | +1.13% |
Jan 28, 2025 | $394.24 | $390.17 | -1.03% |
Oct 29, 2024 | $357.35 | $361.75 | +1.23% |
Jul 30, 2024 | $327.96 | $325.21 | -0.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Stryker Corporation (SYK) report earnings?
Stryker Corporation (SYK) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Stryker Corporation (SYK) earnings time?
Stryker Corporation (SYK) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SYK EPS forecast?
SYK EPS forecast for the fiscal quarter 2025 (Q2) is 3.07.
---